Associate Sponsors

Co-sponsor

Sales rise 3.92% to Rs 135.77 crore

Net Loss of Orchid Pharma reported to Rs 35.60 crore in the quarter ended June 2019 as against net loss of Rs 46.01 crore during the previous quarter ended June 2018. Sales rose 3.92% to Rs 135.77 crore in the quarter ended June 2019 as against Rs 130.65 crore during the previous quarter ended June 2018. ParticularsQuarter EndedJun. 2019Jun. 2018% Var.Sales135.77130.65 4 OPM %-6.91-10.91 -PBDT-4.23-23.53 82 PBT-35.60-56.32 37 NP-35.60-46.01 23

Powered by Capital Market - Live News

Disclaimer: No Business Standard Journalist was involved in creation of this content

More From This Section

First Published: Aug 13 2019 | 5:24 PM IST

Next Story